Novartis AG

Organization

Basel, CH

Ticker Symbols

NYSE:NVS

PHARMACEUTICAL PREPARATIONS
Business Address
LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
Mailing Address
LICHTSTRASSE 35 BASEL V8 CH 4056
State Location
V8
State of Incorporation
V8

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 12,252,535
- Issue date Mar 18, 2025
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Grant
Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...
- Patent number 12,252,478
- Issue date Mar 18, 2025
- Novartis AG
- Stephanie Kay Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...
- Patent number 12,252,479
- Issue date Mar 18, 2025
- Novartis AG
- Stephanie Kay Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyridine derivatives and uses thereof
- Patent number 12,252,482
- Issue date Mar 18, 2025
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhaler
- Patent number D1067421
- Issue date Mar 18, 2025
- Sandoz AG
- Tim Evans
- D24 - Medical and laboratory equipment
Information Patent Grant
Methods for improving the efficacy and expansion of immune cells
- Patent number 12,240,884
- Issue date Mar 4, 2025
- Novartis AG
- Felipe Bedoya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and compositions for inhibiting the activity of HIF2-alph...
- Patent number 12,226,405
- Issue date Feb 18, 2025
- Novartis AG
- Robin Alec Fairhurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell-based assay for measuring drug product potency
- Patent number 12,228,571
- Issue date Feb 18, 2025
- Novartis AG
- Brian Kaspar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD19 binding molecules and uses thereof
- Patent number 12,221,481
- Issue date Feb 11, 2025
- Novartis AG
- Brian Granda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Biomarker predictive of responsiveness to alpha 7 nicotinic acetylc...
- Patent number 12,215,387
- Issue date Feb 4, 2025
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-BCMA chimeric antigen rece...
- Patent number 12,214,037
- Issue date Feb 4, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (P...
- Patent number 12,209,144
- Issue date Jan 28, 2025
- Novartis AG
- Alec Nathanson Flyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inducing chondrogenesis
- Patent number 12,209,096
- Issue date Jan 28, 2025
- Novartis AG
- Ha-Soon Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors for treatment of uveal melanoma
- Patent number 12,208,097
- Issue date Jan 28, 2025
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)i...
- Patent number 12,208,101
- Issue date Jan 28, 2025
- Novartis AG
- Elisabete Goncalves
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 12,209,098
- Issue date Jan 28, 2025
- Novartis AG
- Christine Hiu-Tung Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mavoglurant in the reduction of alcohol use or in preventing...
- Patent number 12,201,612
- Issue date Jan 21, 2025
- Novartis AG
- Ricardo Carl Elciario Dolmetsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug delivery device
- Patent number D1057937
- Issue date Jan 14, 2025
- Sandoz AG
- Leon Rizner
- D24 - Medical and laboratory equipment
Information Patent Grant
Injection device and injection solution transferring system
- Patent number 12,194,278
- Issue date Jan 14, 2025
- Novartis AG
- Nicholas Lee Hawson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...
- Patent number 12,187,703
- Issue date Jan 7, 2025
- Novartis AG
- Cornelius Stephen Harlacher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 12,186,278
- Issue date Jan 7, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CCR7 antibody drug conjugates
- Patent number 12,180,291
- Issue date Dec 31, 2024
- Novartis AG
- Steven Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyridine derivatives and uses thereof
- Patent number 12,172,984
- Issue date Dec 24, 2024
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates for ablating hematopoietic stem cells
- Patent number 12,171,839
- Issue date Dec 24, 2024
- Novartis AG
- Anthony Edward Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means and method for producing and purifying viral vectors
- Patent number 12,168,777
- Issue date Dec 17, 2024
- Novartis AG
- Brian K. Kaspar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 12,161,624
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 12,162,890
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Automatic drug delivery device
- Patent number 12,161,843
- Issue date Dec 10, 2024
- Novartis AG
- Jacques Appy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent targeting of E3 ligases
- Patent number 12,161,648
- Issue date Dec 10, 2024
- The Regents of the University of California
- Jessica Spradlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20250084071
- Publication date Mar 13, 2025
- Novartis Pharma AG
- Shankar Venkatraman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIGITAL SOLUTIONS FOR DIFFERENTIATING ASTHMA FROM COPD
- Publication number 20250087354
- Publication date Mar 13, 2025
- Novartis AG
- Paul Mastoridis
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...
- Publication number 20250082718
- Publication date Mar 13, 2025
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTH...
- Publication number 20250082611
- Publication date Mar 13, 2025
- Novartis AG
- Laura COLEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOSUPPRESSANT FORMULATIONS
- Publication number 20250084034
- Publication date Mar 13, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOSUPPRESSANT FORMULATION
- Publication number 20250073203
- Publication date Mar 6, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20250066479
- Publication date Feb 27, 2025
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20250066462
- Publication date Feb 27, 2025
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME
- Publication number 20250066813
- Publication date Feb 27, 2025
- Novartis AG
- Joseph BALLEYDIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING...
- Publication number 20250066466
- Publication date Feb 27, 2025
- Novartis AG
- Christian MANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20250064964
- Publication date Feb 27, 2025
- Novartis AG
- Anthony Edward BOITANO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydro-Pyrido-Pyrimidine Derivatives
- Publication number 20250059181
- Publication date Feb 20, 2025
- Novartis AG
- Nigel Graham Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS
- Publication number 20250051345
- Publication date Feb 13, 2025
- Novartis AG
- Simon Krautwald
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20250051423
- Publication date Feb 13, 2025
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL DOSING REGIMENS FOR MDM2 INHIBITORS
- Publication number 20250041296
- Publication date Feb 6, 2025
- Novartis AG
- Nelson GUERREIRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
- Publication number 20250041266
- Publication date Feb 6, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof
- Publication number 20250034259
- Publication date Jan 30, 2025
- Novartis AG
- Andrew Marc Stein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20250034270
- Publication date Jan 30, 2025
- Novartis AG
- Christoph HUESSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 '...
- Publication number 20250034156
- Publication date Jan 30, 2025
- Novartis AG
- Maxime DAUPHINAIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SODIUM CHANNEL BLOCKERS
- Publication number 20250034108
- Publication date Jan 30, 2025
- Novartis AG
- Robert Francis DAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-18 BINDING MOLECULES
- Publication number 20250034240
- Publication date Jan 30, 2025
- Novartis AG
- Michael Otto BARDROFF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD AND APPARATUS FOR USING OMALIZUMAB
- Publication number 20250034280
- Publication date Jan 30, 2025
- Novartis AG
- Maria Chaikou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT USING LOU064
- Publication number 20250032488
- Publication date Jan 30, 2025
- Novartis AG
- Souvik BHATTACHARYA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20250034145
- Publication date Jan 30, 2025
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20250034114
- Publication date Jan 30, 2025
- Novartis AG
- Xiaobin Ge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES
- Publication number 20250034241
- Publication date Jan 30, 2025
- Novartis AG
- Markus HEITZMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD AND APPARATUS FOR USING OMALIZUMAB
- Publication number 20250034281
- Publication date Jan 30, 2025
- Novartis AG
- Maria Chaikou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING FACTOR B INHIBITORS
- Publication number 20250025453
- Publication date Jan 23, 2025
- Novartis AG
- Irina BALTCHEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and...
- Publication number 20250026736
- Publication date Jan 23, 2025
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB
- Publication number 20250026858
- Publication date Jan 23, 2025
- Novartis AG
- Reinhold Martin JANOCHA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99016086
- Serial number 99016086
- Filing date Jan 23, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99016129
- Serial number 99016129
- Filing date Jan 23, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98959583 - ORDER360
- Serial number 98959583
- Filing date Jan 14, 2025
- NOVARTIS AG
- 35 - Advertising
Information Trademark
98912297
- Serial number 98912297
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98912317
- Serial number 98912317
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413172 - ITELPREO
- Serial number 79413172
- Filing date Nov 20, 2024
- NOVARTIS AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
79416191 - NOVARTIS RLT CARE
- Serial number 79416191
- Filing date Nov 6, 2024
- NOVARTIS AG
- 35 - Advertising
Information Trademark
79415080 - NOVARTIS RLT CARE
- Serial number 79415080
- Filing date Nov 6, 2024
- NOVARTIS AG
- 35 - Advertising
Information Trademark
79412901 - EDOMIGE
- Serial number 79412901
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79412902 - IGENTZA
- Serial number 79412902
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79412900 - ATLANYS
- Serial number 79412900
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413084 - BYNRAFT
- Serial number 79413084
- Filing date Oct 31, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413085 - AZYATYQ
- Serial number 79413085
- Filing date Oct 31, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413083 - RAFBYX
- Serial number 79413083
- Filing date Oct 31, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98827903 - HS HIDES IN THE SHADOWS
- Serial number 98827903
- Filing date Oct 30, 2024
- NOVARTIS AG
- 44 - Medical services
Information Trademark
98828714 - RHAPSIDO
- Serial number 98828714
- Filing date Oct 30, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98827896 - SHINE A LIGHT ON HS
- Serial number 98827896
- Filing date Oct 30, 2024
- NOVARTIS AG
- 44 - Medical services
Information Trademark
79411050 - STOQUEPT
- Serial number 79411050
- Filing date Oct 17, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413015 - LOQUEPTA
- Serial number 79413015
- Filing date Oct 16, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411051 - STEZYLDA
- Serial number 79411051
- Filing date Oct 16, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411104 - ERELZI
- Serial number 79411104
- Filing date Oct 15, 2024
- Sandoz AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411435 - ZISGOTU
- Serial number 79411435
- Filing date Oct 14, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411434 - KAYUVO
- Serial number 79411434
- Filing date Oct 14, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413359 - EMSUVAY
- Serial number 79413359
- Filing date Oct 14, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411436 - NEUJOYA
- Serial number 79411436
- Filing date Oct 14, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411251
- Serial number 79411251
- Filing date Sep 12, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411252
- Serial number 79411252
- Filing date Sep 12, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411263
- Serial number 79411263
- Filing date Sep 12, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410089 - KWAVRIS
- Serial number 79410089
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411249
- Serial number 79411249
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations

Novartis AG

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Antibody molecules to LAG-3 and uses thereof

Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...

Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...

Pyrazolopyridine derivatives and uses thereof

Inhaler

Methods for improving the efficacy and expansion of immune cells

Compounds and compositions for inhibiting the activity of HIF2-alph...

Cell-based assay for measuring drug product potency

CD19 binding molecules and uses thereof

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylc...

Treatment of cancer using humanized anti-BCMA chimeric antigen rece...

Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (P...

Compounds and compositions for inducing chondrogenesis

Protein kinase C inhibitors for treatment of uveal melanoma

Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)i...

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

Use of mavoglurant in the reduction of alcohol use or in preventing...

Drug delivery device

Injection device and injection solution transferring system

Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Anti-CCR7 antibody drug conjugates

Pyrazolopyridine derivatives and uses thereof

Antibody drug conjugates for ablating hematopoietic stem cells

Means and method for producing and purifying viral vectors

NLRP3 inflammasome inhibitors

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Heteroaromatic NMDA receptor modulators and uses thereof

Automatic drug delivery device

Covalent targeting of E3 ligases

Patents Applicationslast 30 patents

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...

DIGITAL SOLUTIONS FOR DIFFERENTIATING ASTHMA FROM COPD

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...

DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTH...

IMMUNOSUPPRESSANT FORMULATIONS

IMMUNOSUPPRESSANT FORMULATION

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME

METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING...

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

Tetrahydro-Pyrido-Pyrimidine Derivatives

PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

NOVEL DOSING REGIMENS FOR MDM2 INHIBITORS

S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN

Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 '...

SODIUM CHANNEL BLOCKERS

IL-18 BINDING MOLECULES

METHOD AND APPARATUS FOR USING OMALIZUMAB

METHODS OF TREATMENT USING LOU064

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

NLRP3 INFLAMMASOME INHIBITORS

SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES

METHOD AND APPARATUS FOR USING OMALIZUMAB

METHODS OF USING FACTOR B INHIBITORS

3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and...

METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB

Trademarklast 30 trademarks

99016086

99016129

98959583 - ORDER360

98912297

98912317

79413172 - ITELPREO

79416191 - NOVARTIS RLT CARE

79415080 - NOVARTIS RLT CARE

79412901 - EDOMIGE

79412902 - IGENTZA